The Prevalence of the Different Components of the Metabolic Syndrome (MetS) in Obese Nondiabetic Children and Young Adolescents and their Anthropometric Data in Relation to Parents. Metabolic Syndrome in Obese Nondiabetic Children

Main Article Content

Noor Hamed
Ashraf Soliman
Vincenzo De Sanctis
Nada Alaaraj
Fawziya Alyafei
Mona Shaat
Noora Aljaffali
Maya Itani
Celine Jour


Metabolic syndrome, obesity, children, adolescents, standing height, body mass index


 In Qatar, the prevalence of metabolic syndrome (MetS) in children and adolescents is increasing in parallel with the increasing trends in obesity rates. In Qatar, the prevalence of obesity is relatively high. Aim: To assess the prevalence of the different components of MetS and plasma atherogenic indexes (AIP) in obese children and adolescents and to compare their anthropometric data with their parents (genetic background). Methodology: We analysed the anthropometric and biochemical profile of 91 randomly selected obese children and young adolescents (age: 10.5 ± 2.7 years) who attended to the Paediatric Clinic of Hamad Medical Center (HGH) in Doha (Qatar) form January 2017 to December 2019.  Data recorded included: age, gender, weight and height, body mass index (BMI), systolic and diastolic blood pressures. Biochemical data including lipid profile, glycated hemoglobin (A1C), and alanine transferase level (ALT) were recorded and compared with normal lab data for the same age group. Results: Obese children had a high prevalence of dyslipidaemia, dysglycemia and non-alcoholic fatty liver disease (NAFLD). Using the modified adult MetS criteria, MetS was present in 30.2% of this obese cohort. AIP was high in 76.7% of the patients. Standing height standard deviation score (Ht-SDS) of obese children was significantly higher compared to Ht-SDS of their parents as well as to mid-parental height SDS (MPHt-SDS) (-0.37± 0.79). The BMI and BMI-SDS did not differ between obese children and their parents. Conclusion: The occurrence of MetS in 30% of our obese non-diabetic children and young adolescents pointed out to the necessity to impose early detection and preventive measures on a national scale.


Download data is not yet available.
Abstract 61 | PDF Downloads 35


1.Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006; 1:11-25.
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384:766-781.
3. Kann L, McManus T, Harris WA, et al. Youth Risk Behavior Surveillance - United States, 2015. MMWR Surveill Summ. 2016; 65:1-174.
5. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2: 231-237.
6. Weihe P, Weihrauch-Blüher S. Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. Curr Obes Rep. 2019; 8:472-479.
7. Hadjiyannakis S. The metabolic syndrome in children and adolescents. Paediatr Child Health. 2005; 10:41-47.
8.Al-Thani M, Al-Thani A, Alyafei S, et al. The prevalence and characteristics of overweight and obesity among students in Qatar. Public Health. 2018; 160:143-149.
9. Alhyas L, McKay A, Balasanthiran A, Majeed A. Prevalences of overweight, obesity, hyperglycaemia, hypertension, and dyslipidaemia in the Gulf: systematic review. JRSM Short Rep. 2011; 2(7):55. doi: 10.1258/shorts.2011.011019.
10. Syed MA, Al Nuaimi AS, Latif Zainel AJA, Qotba HA. Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study. BMC Public Health. 2020;20(1):611. doi:10.1186/s12889-020-08609-5
11.Alyafei F, Soliman A, Alkhalaf F, et al. Incidence of type 1 and type 2 diabetes, between 2012-2016, among children and adolescents in Qatar. Acta Biomed. 2018;89:7-10.
12.Al Shehri A, Al Fattani A, Al Alwan I. Obesity among Saudi children. Saudi J Obesity. 2013; 1:3-9.
13. Malik M, Bakir A. Prevalence of overweight and obesity among children in the United Arab Emirates. Obes Rev. 2007; 8:15-20.
14. Zhu X, Yu L, Zhou H, et al. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China. Lipids Health Dis. 2018 Mar 5;17(1):37. doi: 10.1186/s12944-018-0686-8.
15.Agudelo GM, Bedoya G, Estrada A, et al. Variations in the prevalence of metabolic syndrome in adolescents according to different criteria used for diagnosis: ¿which definition should be chosen for this age group? Metab Syndr Relat Disord. 2014; 12:202-209.
16. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004; 110:2494-2497.
17. Wittcopp C, Conroy R. Metabolic Syndrome in Children and Adolescents. Pediatr Rev. 2016; 37:193-202.
18. Silveira LS, Buonani C, Monteiro PA, et al. Metabolic Syndrome: Criteria for Diagnosing in Children and Adolescents. Endocrinol Metab Synd. 2013; 2:118.
19. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009; 42:1331-1346.
20.Gepstein V, Weiss R. Obesity as the Main Risk Factor for Metabolic Syndrome in Children. Front Endocrinol (Lausanne). 2019; 10:568. Published 2019 Aug 16. doi:10.3389/fendo.2019.00568.
21.Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560–2572.
22.Færch K, Vistisen D, Johansen NB, Jørgensen ME. Cardiovascular risk stratification and management in pre-diabetes. Curr Diab Rep. 2014 Jun;14(6):493. doi: 10.1007/s11892-014-0493-1..
23.Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103:1175-1182.
24. Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000; 101:1780-1784.
25.Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350:2362-2374.
26.Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122:198–208.
27. Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J Endocrinol Metab. 2013;17:969-976.
28. Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids. 2010;45:907-914.
29. Heslehurst N, Vieira R, Akhter Z, et al. The association between maternal body mass index and child obesity: A systematic review and meta-analysis. PLoS Med. 2019 Jun 11;16(6):e1002817. doi: 10.1371/journal.pmed.1002817
30. Trost SG, Kerr L, Ward DS, Pate RR. Physical activity and determinants of physical activity in obese and non-obese children. Int J Obes Relat Metab Disord. 2001; 25:822–829.
31.Davison KK, Birch LL. Obesigenic families: parents’ physical activity and dietary intake patterns predict girls’ risk of overweight. Int J Obes Relat Metab Disord. 2002; 26:1186–1193.
32. Lobstein T, Baur L, Uauy R IASO International Obesity TaskForce. Obesity in children and young people: a crisis in public health. Obes Rev. 2004;5(Suppl 1):4–104.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>